Yucheng Xiang

673 total citations
38 papers, 537 citations indexed

About

Yucheng Xiang is a scholar working on Molecular Biology, Surgery and Biomedical Engineering. According to data from OpenAlex, Yucheng Xiang has authored 38 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Surgery and 9 papers in Biomedical Engineering. Recurrent topics in Yucheng Xiang's work include Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (7 papers) and RNA Interference and Gene Delivery (5 papers). Yucheng Xiang is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (7 papers) and RNA Interference and Gene Delivery (5 papers). Yucheng Xiang collaborates with scholars based in China, United States and South Korea. Yucheng Xiang's co-authors include Yuan Huang, Lian Li, Liqiang Chen, Xiaoli Yi, Yaxian Zheng, Rui Zhou, Jiawei Wu, Liqiang Chen, Wei Shan and Ling Zhang and has published in prestigious journals such as PLoS ONE, Biomaterials and Advanced Functional Materials.

In The Last Decade

Yucheng Xiang

33 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yucheng Xiang China 14 253 130 111 84 77 38 537
Pradip Chaudhari India 15 311 1.2× 165 1.3× 166 1.5× 81 1.0× 42 0.5× 36 717
Vanminh Le China 14 226 0.9× 159 1.2× 112 1.0× 116 1.4× 66 0.9× 17 583
Jilai Tian China 16 245 1.0× 201 1.5× 155 1.4× 102 1.2× 66 0.9× 32 720
Yihua Yang China 8 242 1.0× 169 1.3× 136 1.2× 39 0.5× 119 1.5× 11 716
Tiantian Tan China 12 268 1.1× 173 1.3× 197 1.8× 47 0.6× 63 0.8× 18 550
Baoyue Ding China 18 372 1.5× 203 1.6× 258 2.3× 59 0.7× 74 1.0× 50 860
Dong‐Sheng Huang China 13 317 1.3× 120 0.9× 82 0.7× 139 1.7× 66 0.9× 31 671
Xiaoyang Chu China 13 295 1.2× 221 1.7× 246 2.2× 36 0.4× 33 0.4× 25 614
Shunping Han United Kingdom 11 285 1.1× 189 1.5× 209 1.9× 36 0.4× 49 0.6× 21 558
Qing Shi China 12 291 1.2× 102 0.8× 127 1.1× 95 1.1× 75 1.0× 39 602

Countries citing papers authored by Yucheng Xiang

Since Specialization
Citations

This map shows the geographic impact of Yucheng Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yucheng Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yucheng Xiang more than expected).

Fields of papers citing papers by Yucheng Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yucheng Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yucheng Xiang. The network helps show where Yucheng Xiang may publish in the future.

Co-authorship network of co-authors of Yucheng Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yucheng Xiang. A scholar is included among the top collaborators of Yucheng Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yucheng Xiang. Yucheng Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Miao, Linlin Zhao, Yujiao Liu, et al.. (2025). Chylomicron-mimicking supramolecular nano emulsion for oral luteolin delivery against hyperuricemia. Pharmaceutical Development and Technology. 30(10). 1543–1556.
2.
Liu, Yang, et al.. (2025). Subcellular Organelle Targeting as a Novel Approach to Combat Tumor Metastasis. Pharmaceutics. 17(2). 198–198. 1 indexed citations
3.
Liu, Jiaqi, et al.. (2025). CXCR4 Clustering Induced by Polymeric Nanothreads Impedes Cancer Cell Metastasis via PIEZO1‐Mediated Mechanotransduction. Advanced Healthcare Materials. 14(24). e2501072–e2501072.
4.
Xiang, Yucheng, et al.. (2025). Recent Advances in Biomimetic Drug Delivery for Rheumatoid Arthritis Treatment. International Journal of Nanomedicine. Volume 20. 14253–14282.
6.
Xu, Bin, et al.. (2024). Combined Chemo- and Photothermal Therapies of Non-Small Cell Lung Cancer Using Polydopamine/Au Hollow Nanospheres Loaded with Doxorubicin. International Journal of Nanomedicine. Volume 19. 9597–9612. 11 indexed citations
7.
Chen, Li, Xinmiao He, Yucheng Xiang, et al.. (2023). Capture of iodine gas by Bi-based composites derived from rice husk: Influence of the type of support on the iodine adsorption and retention. Chemical Engineering Journal. 465. 143069–143069. 38 indexed citations
8.
An, Qi, et al.. (2023). Cell or cell derivative-laden hydrogels for myocardial infarction therapy: from the perspective of cell types. Journal of Materials Chemistry B. 11(41). 9867–9888. 2 indexed citations
9.
Dan, Hui, et al.. (2023). Efficient adsorption of CO2 by amino-functionalized short pore SBA-15: Influence of pore length on adsorption capacity and amino efficiency. Journal of environmental chemical engineering. 11(6). 111379–111379. 5 indexed citations
10.
Xiang, Yucheng, et al.. (2023). Reducing patch-like Errors in SAR offset tracking displacements using logarithmic transformation and a weighted NCC algorithm. Remote Sensing Letters. 14(4). 357–368. 1 indexed citations
11.
Xiao, Xiao, Gaoyang Chen, Song Wang, et al.. (2022). Efficacy of the Dynesys Hybrid Surgery for Patients with Multi-Segmental Lumbar Spinal Stenosis. Frontiers in Surgery. 9. 849679–849679. 1 indexed citations
12.
Li, Lian, et al.. (2022). Split bullets loaded nanoparticles for amplified immunotherapy. Journal of Controlled Release. 347. 199–210. 13 indexed citations
14.
Liu, Zhenghao, Dongkai Zhou, Yucheng Xiang, Cheng Zeng, & Weilin Wang. (2021). Huge portal venous aneurysm incidentaloma caused by intrahepatic arterioportal fistula accompany with hepatobiliary stones and cholangitis. HepatoBiliary Surgery and Nutrition. 10(2). 288–290. 1 indexed citations
15.
Hu, Jie, Zheng Chen, Yifan Wang, et al.. (2020). Reversibility of hAT-MSCs phenotypic and metabolic changes after exposure to and withdrawal from HCC-conditioned medium through regulation of the ROS/MAPK/HIF-1α signaling pathway. Stem Cell Research & Therapy. 11(1). 506–506. 12 indexed citations
16.
Xiang, Yucheng, et al.. (2019). Enhanced intracellular and intranuclear drug delivery mediated by biomimetic peptide SVS-1 for anticancer therapy. International Journal of Pharmaceutics. 570. 118668–118668. 10 indexed citations
17.
Xiang, Yucheng, et al.. (2018). Improved anticancer efficacy of doxorubicin mediated by human-derived cell-penetrating peptide dNP2. International Journal of Pharmaceutics. 551(1-2). 14–22. 17 indexed citations
18.
Kuchta, Kenny, Yucheng Xiang, Shuai Huang, et al.. (2017). Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis. Prostate Cancer and Prostatic Diseases. 20(2). 156–164. 42 indexed citations
20.
Huang, Shuai, Yubo Tang, Xingdong Cai, et al.. (2012). Celastrol inhibits vasculogenesis by suppressing the VEGF-induced functional activity of bone marrow-derived endothelial progenitor cells. Biochemical and Biophysical Research Communications. 423(3). 467–472. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026